SIERRA LEONE — A new Ebola vaccine has approved for human use after numerous successful tests with lab monkeys. The new vaccine is expected to start human trials by early September.
According to World Health Organization (WHO), the vaccine has demonstrated “short-term and partial long-term protection” for the lab monkeys.
Although human testing of the vaccine will begin September, results of the human trials won’t be available until the end of 2014.
As a result, the CDC warns that the Ebola virus could continue to spread across Africa and become more dangerous.
The vaccine, in which scientists say provides “durable protection” against Ebola, helps the cells of the body create an immune response against the virus.
The human trials are expected to be conducted among the individuals not infected with the virus and researchers will be examining whether the vaccine triggers an immune response.
The Ebola virus has so far claimed the lives of over 2,000 people in Africa. This comes after World Health Organization (WHO) warned that Ebola is an international health emergency.